Thomas Yau

11PUBLICATIONS
38CO-AUTHORS
Solid tumoursHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 04, 2026
Anti-Tumor Immunity in Solid-Organ Transplant Recipients.

|Feb 27, 2026
Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study.

Stephen L Chan, Thomas Yau, Robin K Kelley

|Dec 30, 2025
Combined Immunotherapy in Treating Patients with Advanced Hepatocellular Carcinoma.

Karen Hoi Lam Li, Roland Leung, Bryan Cho Wing Li

|Dec 26, 2025
Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study.

Jung Sun Kim, Jeffrey Wong, San-Chi Chen

|Jan 13, 2025
Trifluridine/Tipiracil (FTD/TPI) in Metastatic Colorectal Cancer in Hong Kong: A Territory-Wide Cohort Study.

Ka-On Lam, Karen Hoi-Lam Li, Roland Ching-Yu Leung

|Dec 13, 2022
Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.

Thomas Yau, Vittorina Zagonel, Armando Santoro

Pageof 2

Frequent Collaborators

2 joint publications

Jeffrey Wong

1 joint publications

Kohei Shigeta

1 joint publications

Dan G Duda

1 joint publications

Hin Chu